Navigation Links
Warner Chilcott to Present at Wachovia's 19th Annual Mid-Year Equity Conference
Date:6/19/2009

ARDEE, Ireland, June 19 /PRNewswire-FirstCall/ -- Warner Chilcott Limited (Nasdaq: WCRX) announced today that it will present at Wachovia's 19th Annual Mid-Year Equity Conference on Wednesday, June 24, 2009 at 2:30 p.m. ET. Presenting for Warner Chilcott will be Rochelle Fuhrmann, Senior Director, Investor Relations.

Warner Chilcott's presentation will be webcast live for all interested parties at www.wcrx.com under the Investor Relations tab. An archived version of the webcast will be available for two weeks following the live presentation.

The Company

Warner Chilcott is a leading specialty pharmaceutical company currently focused on the women's healthcare and dermatology segments of the U.S. pharmaceuticals market. The Company is a fully integrated company with internal resources dedicated to the development, manufacturing and promotion of its products. WCRX-G


'/>"/>
SOURCE Warner Chilcott Limited
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Senators Webb and Warner Vote to Protect Americas Kids From Tobacco
2. Warner Chilcott to Present at the Goldman Sachs 30th Annual Healthcare Conference
3. Warner Chilcott Announces FDA Acceptance of NDA Submission for Low Dose Oral Contraceptive
4. Warner Chilcott Reports Operating Results for the Quarter Ended March 31, 2009 and Updates 2009 Full Year Guidance
5. Warner Chilcott Proposes Redomestication From Bermuda to Ireland
6. Warner Chilcott to Present at the Bank of America and Merrill Lynch 2009 Health Care Conference
7. Warner Chilcott Files New Lawsuit for Infringement of DORYX(R) Patent
8. HBO, Warner Bros. Employee Initiatives and the Alzheimers Association, California Southland Chapter Present a Free, Public, Advance Screening of THE ALZHEIMERS PROJECT: Caregivers
9. Warner Chilcott Announces Earnings Release Date and Conference Call For First Quarter 2009 Financial Results
10. Warner Chilcott Files New Lawsuit for Infringement of DORYX(R) Patent
11. Warner Chilcott Announces Receipt of FDA Response to Citizen Petition
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/20/2017)... Houston, TX (PRWEB) , ... February 20, 2017 ... ... he is now offering a full range of emergency dental care at his ... teeth and gums. When patients experience dental emergencies, they are at risk for ...
(Date:2/20/2017)... ... February 20, 2017 , ... Florida Hospital Pepin Heart Institute ... thrombolysis machine, a state-of-the-art device that breaks up life-threatening blood clots by combining ... Foundation. , “We greatly appreciate this gift from Constellation Brands. We are also ...
(Date:2/19/2017)... RI (PRWEB) , ... February 19, 2017 , ... ... is proven to result in better care, and MEDfx and the Delaware Health ... state of Delaware. , As the nation’s first state-wide health information exchange, DHIN ...
(Date:2/18/2017)... ... February 17, 2017 , ... Butler Mobility invited Ken ... Stairlift and other Butler products. Ken was impressed with the safety and reliability ... endorse the product on his show. This endorsement by Ken Matthews can be ...
(Date:2/18/2017)... ... 2017 , ... A new directory from the Senior Veterans ... connect elderly veterans of America's armed forces to a range of senior care ... on this year's increase in the Veterans Pension with Aid & Attendance for ...
Breaking Medicine News(10 mins):
(Date:2/19/2017)... , February 18, 2017 Marapharm ... to purchase a Medical Delivery Service with the specific ... transactions between qualified patients and caregivers. The delivery service ... located in the Coachella Valley, California ... Los Angeles area to the West, population ...
(Date:2/18/2017)... Feb. 17, 2017  Pharmaceutical companies have long used advisory ... in development or already on the market.   ... industry to alter how it manages advisory board meetings. To ... Practices, LLC conducted a new study focused on key aspects ... ...
(Date:2/17/2017)... NEW HAVEN, Conn. , Feb. 17, 2017 /PRNewswire/ ... new class of drugs based on protein degradation, today ... oral androgen receptor (AR) PROTAC during a poster session ... Cancers Symposium (ASCO GU) in Orlando, FL. ... today continue to validate our platform and the potential ...
Breaking Medicine Technology: